ArticleJournal of clinical and translational hepatology2021

Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis.

Limin An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.